Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ziyin Tian"'
Publikováno v:
Nutrition & Metabolism, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Background D-mannose, an epimer of glucose, which is abundant in some fruits, such as cranberry, has been previously reported to inhibit urinary tract infection. In recent years, the potential function of D-mannose has been broadened into th
Externí odkaz:
https://doaj.org/article/8589f0bc3fa74c66b60c903aabb92f1a
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e28600- (2024)
The programmed death-ligand 1 (PD-L1) on the surface of tumor cells binds to the receptor programmed cell death protein 1 (PD-1) on effector T cells, thereby inhibiting the anti-tumor immune response. Immune checkpoint blockade (ICB) therapy targetin
Externí odkaz:
https://doaj.org/article/3eebf51175114ce08d05b3bd3bf9c76f
Autor:
Ziyin Tian, Yan Yang, He Wu, Yongye Chen, Hao Jia, Lei Zhu, Runjia He, Yibo Jin, Bei Zhou, Chunpo Ge, Yanxia Sun, Yun Yang
Publikováno v:
Heliyon, Vol 8, Iss 8, Pp e10410- (2022)
The dual tyrosine kinase (EGFR/HER2) inhibitor lapatinib is currently used to clinically treat HER2-positive breast cancer. However, a majority of patients do not respond to lapatinib therapy within 6 months. Therefore, potentiating the anti-tumor ef
Externí odkaz:
https://doaj.org/article/0cda42353b374491acc3d881568451cc
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Background and Purpose: Although trastuzumab has shown considerable activity in the treatment of HER2-positive breast and gastric cancers, a significant proportion of patients do not respond to trastuzumab. Recent studies revealed that osthole, an ac
Externí odkaz:
https://doaj.org/article/03c5b8bd1c2b4324ae01723773181c96
Autor:
Yun Yang, Ziyin Tian, Yanke Ding, Xiaojing Li, Ziheng Zhang, Liu Yang, Fangyu Zhao, Feng Ren, Rui Guo
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Previously, we developed a novel EGFR-targeted antibody (denoted as Pan), which has superior antitumor activity against EGFR-overexpressed tumors. However, it shows marginal effect on the growth of esophageal cancers. Therefore, the variable region o
Externí odkaz:
https://doaj.org/article/d1aa902408a44b7694d01c3929c20153
Publikováno v:
Photochemical & Photobiological Sciences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03b12ba80472493da2be1ca27252e3c6
https://doi.org/10.1007/s43630-023-00365-w
https://doi.org/10.1007/s43630-023-00365-w
Autor:
Ziyin Tian, Yan Yang, He Wu, Yongye Chen, Hao Jia, Lei Zhu, Runjia He, Yibo Jin, Bei Zhou, Chunpo Ge, Yanxia Sun, Yun Yang
Overexpression of human epidermal growth factor receptor 2 (HER2), a member of the HER family of receptor tyrosine kinases (RTKs), is found in many solid tumors. The dual tyrosine kinase (EGFR/HER2) inhibitor lapatinib is currently used to clinically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04c7ad1b6ec3408127b7e70e0f5a132b
https://doi.org/10.21203/rs.3.rs-1564524/v1
https://doi.org/10.21203/rs.3.rs-1564524/v1
Publikováno v:
Oncology Letters
Dithiocarbamate has been reported to possess a potent antitumor efficacy against several types of cancer, such as ovarian cancer, breast cancer and hepatocellular carcinoma; however, only a few studies have investigated its inhibitory effect on esoph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a8933e0187758cf1277fb76bb20701
https://doi.org/10.3892/ol.2020.11638
https://doi.org/10.3892/ol.2020.11638
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2020 (2020)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
The HER2-targeting antibody trastuzumab has shown effectiveness in treating HER2-positive breast and gastric cancers; however, its responses are limited. Currently, Nrf2 has been deemed as a key transcription factor in promoting cancer progression an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8be239a15b8fa86c6b353fb0e8401bb
https://doaj.org/article/d7b0de7e3bf445e18990aec0603532d9
https://doaj.org/article/d7b0de7e3bf445e18990aec0603532d9